Company Overview of Fabre-Kramer Pharmaceuticals, Inc.
Key Executives for Fabre-Kramer Pharmaceuticals, Inc.
|Stephen J. Kramer M.D.||No Relationships||Chief Executive Officer||--|
|Edward H. Koehler Jr., MS MBA||No Relationships||Chief Financial Officer and Executive Vice President of Licensing & Business Development||--|
Fabre-Kramer Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Davis L. Temple Jr., Ph.D.||12 Relationships||Fabre-Kramer Pharmaceuticals, Inc.||--|
|Karl Rickels M.D.||2 Relationships||Fabre-Kramer Pharmaceuticals, Inc.||--|
|Stuart A. Montgomery B.SC., M.D., F.R.C. Psych.||41 Relationships||Fabre-Kramer Pharmaceuticals, Inc.||--|
Fabre-Kramer Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.